<?xml version="1.0" encoding="UTF-8"?>
<p>Of the 42 seropositive individuals in the bDMARD user group, 32 (76%) were symptomatic, and among the controls, 14 (93%) of the 15 seropositive individuals developed symptoms (
 <italic>p</italic>=0.87). The demographic clinical data of the sample can be seen in 
 <xref rid="tab1" ref-type="table">Table 1</xref>.
</p>
